TY - JOUR
T1 - Safety of intravitreal clindamycin in albino rabbit eyes
AU - Habot-Wilner, Zohar
AU - Mazza, Orit
AU - Shahar, Jonathan
AU - Massarweh, Amir
AU - Mann, Irit
AU - Loewenstein, Anat
AU - Perlman, Ido
N1 - Publisher Copyright:
© 2017, Springer-Verlag GmbH Germany.
PY - 2017/10/1
Y1 - 2017/10/1
N2 - Purpose: To study the potential toxic effects of intravitreal clindamycin on the retina of albino rabbits, by assessing functional and morphological retinal changes. Methods: Eight albino rabbits were included in the study. In each rabbit, 1 mg/0.1 ml clindamycin was injected into the vitreous of the right (experimental) eye, and 0.1 ml saline was injected into the vitreous of the left (control) eye. The electroretinogram (ERG) was recorded before injection, 3 days, 1, 2, and 4 weeks post-injection. The visual evoked potential (VEP) was recorded 4 weeks post-injection. Clinical examination was conducted at all time points. The eyes were enucleated at the termination of the follow-up period in order to prepare the retinas for histology in order to assess retinal structure. Results: ERG and VEP responses that were recorded from the experimental eye at different times following intravitreal clindamycin injection were very similar to the corresponding responses that were recorded from the control eyes. Clinical examination was normal in all eyes, and no histological damage was observed. Conclusions: Intravitreal injection of 1 mg clindamycin does not cause functional or morphological signs of retinal toxicity in albino rabbits, during a period of 4 weeks post-injection. These findings support the clinical use of 1 mg intravitreal clindamycin.
AB - Purpose: To study the potential toxic effects of intravitreal clindamycin on the retina of albino rabbits, by assessing functional and morphological retinal changes. Methods: Eight albino rabbits were included in the study. In each rabbit, 1 mg/0.1 ml clindamycin was injected into the vitreous of the right (experimental) eye, and 0.1 ml saline was injected into the vitreous of the left (control) eye. The electroretinogram (ERG) was recorded before injection, 3 days, 1, 2, and 4 weeks post-injection. The visual evoked potential (VEP) was recorded 4 weeks post-injection. Clinical examination was conducted at all time points. The eyes were enucleated at the termination of the follow-up period in order to prepare the retinas for histology in order to assess retinal structure. Results: ERG and VEP responses that were recorded from the experimental eye at different times following intravitreal clindamycin injection were very similar to the corresponding responses that were recorded from the control eyes. Clinical examination was normal in all eyes, and no histological damage was observed. Conclusions: Intravitreal injection of 1 mg clindamycin does not cause functional or morphological signs of retinal toxicity in albino rabbits, during a period of 4 weeks post-injection. These findings support the clinical use of 1 mg intravitreal clindamycin.
KW - Clindamycin
KW - ERG
KW - Intravitreal injection
KW - Retina
KW - Retinal toxicity
KW - VEP
UR - http://www.scopus.com/inward/record.url?scp=85025831259&partnerID=8YFLogxK
U2 - 10.1007/s10633-017-9599-5
DO - 10.1007/s10633-017-9599-5
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 28744691
AN - SCOPUS:85025831259
SN - 0012-4486
VL - 135
SP - 133
EP - 146
JO - Documenta Ophthalmologica
JF - Documenta Ophthalmologica
IS - 2
ER -